Global News

[ad_1] A Science employee at work in the lab. Courtesy: Science Corporation Biotechnology startup and Neuralink competitor Science on Monday launched a new platform that aims to make it easier for other companies to quickly develop and produce medical devices.  The platform, called Science Foundry, allows companies to utilize and build upon Science's internal infrastructure by offering access to more than 80 of its tools and services, like the company's thin-film electrode technologies. The cost of the technology required to develop medical devices is often "prohibitive" for early-stage startups, Science Co-Founder and CEO Max Hodak told CNBC in an interview. Individual tools can cost anywhere from $200,000 to $2 million, and Hodak said companies could easily spend hundreds of millions building a manufacturing line.  For many startups, that cost is too much to bear, but Hodak is hoping Science Foundry can help. "Hopefully, we bring down the barriers to innov

[ad_1] Amazon CEO Andy Jassy doesn't believe the retail and cloud computing giant should be counted out of the artificial intelligence race just yet. In a wide-ranging interview with CNBC, Jassy challenged the notion that Amazon has fallen behind in AI as Microsoft and Google add chatbots to consumer products like their search engines, likening it to the "hype cycle" before the "substance cycle." "I think most people are focused on the applications, you know, things like ChatGPT brought everybody's awareness up, but I think of generative AI as having three macro layers," Jassy told Jon Fortt in an interview that aired on "Closing Bell Overtime" late Thursday. "I think they're all really big and important." Jassy has said Amazon intends to invest in AI across the company, and that AI programs have the potential to improve "virtually every customer experience." But he specifically pointed to Amazon Web Servi